Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain McInnes

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
JCI Insight|February 22, 2022
Dissecting the molecular control of immune cell accumulation in the inflamed jointCatriona T Prendergast, Robert A Benson, Hannah E Scales, et al.
The Journal of Infectious Diseases|April 18, 2012
Interleukin 15 mediates joint destruction in Staphylococcus aureus arthritisLouise Henningsson, Pernilla Jirholt, Yalda Rahpeymai Bogestål, et al.
The Journal of Rheumatology|February 17, 2017
Plasma Levels of Eicosapentaenoic Acid Are Associated with Anti-TNF Responsiveness in Rheumatoid Arthritis and Inhibit the Etanercept-driven Rise in Th17 Cell Differentiation <i>in Vitro</i>Louisa Jeffery, Helena L Fisk, Philip C Calder, et al.
Annals of the Rheumatic Diseases|May 9, 2020
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritisAndreas Kerschbaumer, Josef S Smolen, Maxime Dougados, et al.
Arthritis and Rheumatism|May 27, 2006
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritisElli Kruithof, Leen De Rycke, Bernard Vandooren, et al.
Frontiers in Immunology|June 6, 2018
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid ArthritisFaye A H Cooles, Amy E Anderson, Andrew Skelton, et al.
Arthritis and Rheumatism|April 1, 2009
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled studyArthur Kavanaugh, Iain McInnes, Philip Mease, et al.
Autoimmunity Reviews|December 16, 2020
Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatmentMads Brüner, Anders Dige, Anne Gitte Loft, et al.
Annals of the Rheumatic Diseases|January 4, 2014
TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritisDominika E Nanus, Andrew D Filer, Beverly Hughes, et al.
Arthritis Care & Research|January 8, 2020
Treatment-to-Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease ManifestationsPhilip J Mease, Dafna D Gladman, Alexis Ogdie, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
JCI Insight|February 22, 2022
Dissecting the molecular control of immune cell accumulation in the inflamed jointCatriona T Prendergast, Robert A Benson, Hannah E Scales, et al.
The Journal of Infectious Diseases|April 18, 2012
Interleukin 15 mediates joint destruction in Staphylococcus aureus arthritisLouise Henningsson, Pernilla Jirholt, Yalda Rahpeymai Bogestål, et al.
The Journal of Rheumatology|February 17, 2017
Plasma Levels of Eicosapentaenoic Acid Are Associated with Anti-TNF Responsiveness in Rheumatoid Arthritis and Inhibit the Etanercept-driven Rise in Th17 Cell Differentiation <i>in Vitro</i>Louisa Jeffery, Helena L Fisk, Philip C Calder, et al.
Annals of the Rheumatic Diseases|May 9, 2020
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritisAndreas Kerschbaumer, Josef S Smolen, Maxime Dougados, et al.
Arthritis and Rheumatism|May 27, 2006
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritisElli Kruithof, Leen De Rycke, Bernard Vandooren, et al.
Frontiers in Immunology|June 6, 2018
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid ArthritisFaye A H Cooles, Amy E Anderson, Andrew Skelton, et al.
Arthritis and Rheumatism|April 1, 2009
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled studyArthur Kavanaugh, Iain McInnes, Philip Mease, et al.
Autoimmunity Reviews|December 16, 2020
Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatmentMads Brüner, Anders Dige, Anne Gitte Loft, et al.
Annals of the Rheumatic Diseases|January 4, 2014
TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritisDominika E Nanus, Andrew D Filer, Beverly Hughes, et al.
Arthritis Care & Research|January 8, 2020
Treatment-to-Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease ManifestationsPhilip J Mease, Dafna D Gladman, Alexis Ogdie, et al.
Pageof 6